Report ID : 10078417 |
Published Date : 21 Oct 2022 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
Global Insulin Delivery Devices Industry was valued approximately USD 11.55 Billion in 2016 is anticipated to grow with healthy growth rate of more than 9.09% over the forecast period 2017-2025. The Key drivers in the Industry include Government support in specific countries, favorable reimbursement technological advancements in insulin delivery devices, and rising diabetic population.
The objective of the study is to define Industry sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the Industry. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players.
The major market players in Insulin Delivery Devices Industry are Novo Nordisk A/S, Sanofi, Eli Lilly and Company Biocon Ltd., Wockhardt Ltd and Medtronic. The companies are spending a lot on their research and development programs to keep up with the dynamically changing technologies in the Industry.
Insulin Delivery Devices Industry Segmentation:
By Product Type:
Insulin syringes
Insulin pens
Insulin pumps
Insulin injectors
By Region:
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
T
